Ipatasertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
This report contains market size and forecasts of Ipatasertib in global, including the following market information:
Global Ipatasertib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ipatasertib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ipatasertib companies in 2021 (%)
The global Ipatasertib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ipatasertib include Abcam, Cayman Chemical, Selleck Chemicals, BOC Sciences, BioVision, Adooq Bioscience, Focus Biomolecules, Biorbyt and AbMole, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ipatasertib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ipatasertib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ipatasertib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Ipatasertib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ipatasertib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Ipatasertib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ipatasertib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ipatasertib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ipatasertib revenues share in global market, 2021 (%)
Key companies Ipatasertib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ipatasertib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Cayman Chemical
Selleck Chemicals
BOC Sciences
BioVision
Adooq Bioscience
Focus Biomolecules
Biorbyt
AbMole
LifeSpan BioSciences
MyBiosource
LGC
MuseChem
Shimadzu
Taiclone
Aladdin